Bacil Pharma Share Price
18 Aug, 2026 4:01 PM (IST)
Bacil Pharma Performance
- Today's Low
- ₹12
- Today's High
- ₹12
- 52 Week Low
- ₹12
- 52 Week High
- ₹62
- Open Price₹12
- Previous Close₹13
- Volume7,728
- 50 DMA₹29.70
- 100 DMA₹36.70
- 200 DMA₹39.80
Bacil Pharma Chart
Investment Returns
- Over 1 Month -67.47%
- Over 3 Month -79.19%
- Over 6 Month -72.07%
- Over 1 Year -68.4%
Smart Investing Starts Here Start SIP with Bacil Pharma for Steady Growth!
Bacil Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 25.9
- PEG Ratio
- -0.6
- Market Cap Cr
- 17
- P/B Ratio
- 0.7
- Average True Range
- 1.3
- EPS
- 0.5
- Dividend Yield
- 0
- MACD Signal
- -6.1
- RSI
- 5.46
- MFI
- -
Latest Stock News Updates
Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 ,inter alia, to consider and approve Board meeting to be held on 25th August 2026 for Discussion on Appointment of Directors
- BSE India
- 20 hours 47 minutes ago
Un-audited Financial Results for the Quarter Ended 30th June, 2026
- BSE India
- 6 days 3 hours ago
Outcome of Board Meeting held on 12th August, 2026
- BSE India
- 6 days 3 hours ago
Bacil Pharma Financials
Bacil Pharma Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹19.90
- 50 Day
- ₹29.70
- 100 Day
- ₹36.70
- 200 Day
- ₹39.80
Resistance and Support
- R3 11.80
- R2 11.80
- R1 11.80
- S1 11.80
- S2 11.80
- S3 11.80
Bacil Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-12 | Quarterly Results | |
| 2026-07-09 | Others | Inter-alia, to consider 1. Proposal for raising funds by way of a Rights Issue of equity shares. 2. Consequent alteration of the Capital Clause of the MOA of the Company. 3. Other business matters. |
| 2026-06-26 | Fund Raising & Others | Inter-alia to consider 1. Proposals for raising funds by the Company through one or more permissible modes, subject to such statutory & regulatory. 2.Preferential Issue. 3. Other business matters. |
| 2026-05-22 | Audited Results | |
| 2026-02-13 | Quarterly Results |
About Bacil Pharma
Bacil Pharma main object of the Company is to undertake Pharmaceutical business. View More- NSE Symbol
- BACPHAR
- BSE Symbol
- 524516
- ISIN
- INE711D01018
Similar Stocks to Bacil Pharma
Popular Stocks
Bacil Pharma FAQs
Bacil Pharma share price is ₹11 As on 18 August, 2026 | 19:26
The Market Cap of Bacil Pharma is ₹17 Cr As on 18 August, 2026 | 19:26
The P/E ratio of Bacil Pharma is 25.9 As on 18 August, 2026 | 19:26
The PB ratio of Bacil Pharma is 0.7 As on 18 August, 2026 | 19:26
The 52 week High & Low of Bacil Pharma is ₹61.8/₹11.8 respectively As on 18 August, 2026 | 19:26
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.